Clinical Study on Treatment of Migraine with AnXian-lamotrigine (LTG): an open-label controlled study

Authors
Category Primary study
Registry of TrialsChinese Clinical Trial Register
Year 2009
INTERVENTION: Group A:Lamotrigine;Group B:Lamotrigine together with Flunarizine;Group C:Other Anti‐Epilepsy Drugs (AEDs) transferred to Lamotrigine;Group D:Other Anti‐Epilepsy Drugs (AEDs) transferred to Lamotrigine together with Flunarizine; CONDITION: migraine PRIMARY OUTCOME: Change in the Number of Migraine Days;MIGSEV scale;Frequency of Migraine; SECONDARY OUTCOME: quality of life; INCLUSION CRITERIA: 1. Male and female patients aged 15 to 75 years old who were concordant for migraine of International Headache Society (2003); 2. Admitted in Nanjing Brain Hospital between Jan 1st 2009 and Dec 31 2010; 3. Diagnosed by experienced physicians; 4. signed the consent form.
Epistemonikos ID: 114647f2aa3aae9f3851f786e0a7af495e0be37e
First added on: Aug 22, 2024